Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
79.36B | 102.41B | 124.47B | 83.97B | 53.68B | Gross Profit |
39.85B | 53.97B | 64.99B | 40.80B | 24.49B | EBIT |
32.95B | 39.27B | 53.26B | 31.00B | 20.05B | EBITDA |
31.86B | 52.30B | 70.05B | 44.90B | 16.99B | Net Income Common Stockholders |
5.92B | 24.88B | 36.62B | 19.88B | 1.14B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.54B | 15.55B | 10.77B | 11.12B | 12.37B | Total Assets |
181.87B | 217.07B | 187.19B | 174.35B | 190.01B | Total Debt |
60.39B | 62.60B | 53.80B | 58.74B | 75.54B | Net Debt |
57.11B | 49.87B | 45.80B | 48.28B | 63.83B | Total Liabilities |
122.45B | 138.09B | 117.36B | 104.54B | 130.13B | Stockholders Equity |
59.18B | 78.58B | 69.49B | 69.41B | 59.35B |
Cash Flow | Free Cash Flow | |||
20.08B | 31.10B | 40.14B | 31.47B | 23.02B | Operating Cash Flow |
32.99B | 43.21B | 49.72B | 37.79B | 28.89B | Investing Cash Flow |
-11.70B | -7.96B | -432.00M | 2.16B | -4.51B | Financing Cash Flow |
-29.10B | -30.70B | -51.45B | -40.79B | -19.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $191.09B | 12.55 | 8.82% | 4.33% | -5.74% | -11.09% | |
79 Outperform | $63.90B | 7.50 | 19.39% | 4.90% | -4.07% | -20.34% | |
78 Outperform | $122.06B | 8.41 | 13.43% | 4.80% | -10.66% | -23.19% | |
77 Outperform | $43.55B | 16.53 | 5.58% | 5.18% | -5.16% | -41.74% | |
76 Outperform | $79.45B | 12.47 | 10.52% | 20.11% | -10.81% | -70.65% | |
61 Neutral | $75.23B | 198.74 | 0.59% | 6.54% | -9.97% | -98.08% | |
57 Neutral | $7.70B | 4.18 | -3.52% | 8.32% | 0.35% | -64.68% |